Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.53
Delayed Data
As of 4:00pm ET
 -0.0212 / -3.85%
Today’s Change
0.53
Today|||52-Week Range
0.96
-24.29%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.55
Today’s open0.55
Day’s range0.53 - 0.57
Volume565,376
Average volume (3 months)596,211
Market cap$98.8M
Dividend yield--
Data as of 4:00pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
XOMAXOMA Corp+0.05+6.30%
CNATConatus Pharmaceutic...+0.12+2.45%
CTRVContraVir Pharmaceut...+0.17+3.91%
PVCTProvectus Biopharmac...+0.04+8.51%
Data as of 3:59pm ET, 07/28/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer &
Secretary
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers